cMLCK is the predominant protein kinase that maintains basal RLC phosphorylation required for normal physiological cardiac performance in vivo.
No takes yet. Share an insight, caveat, or question.
cMLCK modulation warrants no clinical action yet; leaves open its therapeutic targeting in human heart failure.
Ding et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: